MassVentures meets critical capital needs in the Massachusetts innovation economy, providing seed and early-stage venture funding to high growth startups as they move from concept to commercialization. The Boston-based venture firm was formed in 1978 as a quasi-public corporation by the Legislature of the Commonwealth of Massachusetts, governed by an independent Board of Directors, and managed by experienced venture capitalists. Leveraging the entrepreneurial spirit, educated workforce, and centers of innovation in Massachusetts, MassVentures has a track record of success with early-stage ventures.

Techstars Central LLC, founded in 2006 and based in Boulder, Colorado, operates as a startup accelerator and venture capital firm focused on supporting early-stage technology-oriented companies. It specializes in a mentorship-driven accelerator program, selecting ten startups each summer to participate in a three-month incubation period, offering funding of $120,000 in exchange for equity. Techstars invests primarily in sectors such as fintech, artificial intelligence, blockchain, augmented reality, and IoT, while avoiding investments in medical devices, healthcare technology, and local service-oriented businesses. In addition to its primary accelerator, Techstars has various specialized programs, including those focused on music, retail, mobility, and social impact, with global reach extending to regions such as Africa, Asia, and Latin America. The firm prefers taking minority stakes, typically between six and ten percent, without seeking board representation or investor rights. Techstars has built a robust network of entrepreneurs, mentors, and corporate partners to foster innovation and growth within its portfolio, which includes over 1,000 companies with a significant collective market capitalization.

RA Capital Management, L.P. is a Boston-based venture capital firm focused on growth capital and early-stage investments in the healthcare and life sciences sectors. Established in 2001, the firm specializes in funding companies involved in drug development, medical devices, diagnostics, and biotechnology. It engages in a range of investment stages, from seed funding to later rounds and public offerings, often preferring to co-invest and take board positions. RA Capital targets companies that are innovating in areas such as prevention, cost-effective diagnostics, genetic testing, and personalized medicine. The firm is staffed by professionals with backgrounds in biology, chemistry, and medicine, providing them with a deep understanding of the scientific and regulatory landscape. This expertise allows RA Capital to identify promising technologies and offer strategic guidance, including potential partnerships and insights into public market demands.

Atlas Venture L.P. is a private equity and venture capital firm based in Cambridge, Massachusetts, founded in 1980. The firm specializes in early-stage investments, primarily in the life sciences and technology sectors. In life sciences, Atlas Venture focuses on biotechnology, therapeutics, medical technologies, and personalized medicine. In technology, it targets areas such as fintech, consumer innovation, and emerging web services. The firm employs a seed-led venture creation strategy that emphasizes rigorous selection of promising startups led by capable entrepreneurs. Atlas Venture typically invests between $500,000 and $5 million in its portfolio companies, often taking the lead role and seeking board representation. The firm manages over $2 billion in committed capital and has been involved with more than 350 companies across various countries. Its investment strategy prioritizes opportunities in the United States, particularly in regions such as New England and California.

[Connecticut Innovations](http://www.ctinnovations.com) provides strategic capital and operational insight to to companies in high-tech industries such as energy, biotechnology, information technology, and photonics. Their mission is to be the leading source of financing and ongoing support for Connecticut’s innovative, growing companies. By offering flexible financing, strategic guidance and introductions to valuable partners, Connecticut innovations enable promising businesses to thrive.

The Massachusetts Clean Energy Center (MassCEC) is a state agency established to promote the growth of the clean energy sector in Massachusetts. Founded in 2009 under the Green Jobs Act, MassCEC focuses on accelerating job creation and economic development within the clean energy industry. The organization provides early-stage investments to startups, offers renewable energy rebates for residents and businesses, and supports workforce development initiatives to prepare individuals for careers in clean energy. By leveraging the state's unique assets, MassCEC aims to facilitate the development of renewable energy projects and establish Massachusetts as a leader in the national and global clean energy landscape.

Polaris Partners is a venture capital firm founded in 1996 and headquartered in Boston, Massachusetts. With a focus on technology and healthcare sectors, Polaris invests in companies at all stages of development, from inception to profitable growth. The firm has a history of partnering with experienced entrepreneurs and innovators, aiming to enhance the way people live and work. In addition to its Boston headquarters, Polaris has offices in San Francisco and New York, and it actively targets investments in life sciences, biotechnology, and software industries across the United States and Europe. Over its more than two-decade history, Polaris Partners has established itself as a multibillion-dollar investment firm committed to fostering innovation and entrepreneurship.

General Catalyst Group Management, LLC is a private equity and venture capital firm founded in 2000 and based in Cambridge, Massachusetts, with additional offices in North America and Europe. The firm specializes in early-stage and growth equity investments, focusing on a diverse range of sectors including technology, advanced materials, clean energy, cybersecurity, healthcare, and consumer services. General Catalyst seeks to invest in companies that demonstrate strong growth potential, typically targeting those with an EBITDA between $3 million and $30 million and minimum revenues of $10 million. The firm has managed eight venture capital funds with approximately $3.75 billion in capital commitments. It emphasizes building lasting relationships with entrepreneurs and provides mentorship to foster success, enabling companies to scale effectively. General Catalyst primarily invests in North America and Australia, with a preference for seed investments in Silicon Valley, New York, and Boston.

GV Management Company, LLC, established in 2009 as the venture capital arm of Alphabet Inc., specializes in investments across various stages, including seed, early, and late-stage funding. Based in Mountain View, California, with additional offices in Boston, New York, Seattle, Cambridge, and London, GV focuses on sectors such as life sciences, healthcare, artificial intelligence, robotics, transportation, cybersecurity, and agriculture. The firm has invested in over 300 companies, aiming to drive innovation and improve lives. GV seeks to make investments of up to $50 million, while offering early-stage startups funding of up to $250,000, typically taking minority stakes in these companies. Through its extensive network, GV provides startups with unique access to technology and talent, enhancing their potential for success.

Alumni Ventures Group, LLC is a venture capital firm founded in 2013 and based in Manchester, New Hampshire, with additional offices in North America. The firm specializes in seed, early-stage, and late-stage pre-IPO investments, focusing on companies that have an alumni connection and an institutional lead investor with relevant expertise. It offers high-quality, diversified venture portfolios to individual investors, particularly accredited alumni from top entrepreneurial schools, who previously lacked access to venture capital opportunities. Alumni Ventures Group invests between $0.01 million and $3 million in various sectors and geographies, without seeking board or observer seats. Additionally, the firm provides focused funds that enable any accredited investor to access a diverse venture portfolio, allowing for investment across different types, sectors, stages, and geographical locations.

MASSACHUSETTS CAPITAL RESOURCE COMPANY was established in 1977 as a limited partnership privately owned and funded by Massachusetts-based life insurance companies. The Company’s mission was to create a source of risk capital to fill the senior debt to equity funding “gap” experienced by growing companies. Their investment activity complements, rather than competes with, the financing provided by senior lenders and equity investors. Mass. Capital provides higher risk growth and acquisition capital to manufacturing, distribution, service and technology companies. They focus on emerging growth and middle market companies with operations in Massachusetts. Their investments are structured to fit the specific needs of portfolio companies and to complement funding available from senior lenders and equity investors.

Wellington Management Company LLP, founded in 1928 and headquartered in Boston, Massachusetts, is a prominent investment management firm providing comprehensive solutions to institutional clients worldwide. The firm specializes in a diverse range of investment strategies, including equity, fixed income, multi-asset, and alternative investments, tailored to meet the unique return and risk objectives of its clients. Wellington Management employs a collaborative approach, leveraging proprietary research and analytical tools to identify opportunities and manage risks across global capital markets. The firm caters to a wide array of clients, including sovereign institutions, endowments, foundations, wealth managers, and insurance companies, spanning more than 50 countries. With a focus on long-term investment principles, Wellington Management fosters independent thought and debate within its teams, ensuring that resources are effectively utilized to deliver consistent results. The firm also emphasizes environmental, social, and governance (ESG) considerations in its research and investment processes, engaging with companies on key ESG topics.

OrbiMed Advisors LLC is a healthcare-focused investment firm founded in 1989, managing approximately $5 billion in assets. The firm specializes in a range of investment strategies, including private equity, venture capital, and public equity, targeting companies across the healthcare spectrum—from startups to large multinational corporations. OrbiMed invests in various sectors within the healthcare industry, including pharmaceuticals, biotechnology, life sciences, medical devices, and health IT. The firm typically invests between $3 million and $150 million, often seeking majority stakes in its portfolio companies. With a global investment approach, OrbiMed operates from offices in New York, San Francisco, Mumbai, Herzliya, Shanghai, West Kowloon, and Luxembourg, focusing on opportunities in North America, Europe, Asia, and Israel. Its investment strategies are underpinned by fundamental analysis, encompassing investments in public equity, fixed income, and alternative markets.

F Prime, Inc. is a venture capital firm based in Cambridge, Massachusetts, with additional offices in San Francisco and London. Founded in 1969, it is part of the legacy of Fidelity Investments, one of the largest asset management firms in the world. F Prime focuses on investing in North American and European companies across various sectors, including healthcare, life sciences, medtech, technology, and health information technology. The firm operates several specialized funds, such as those dedicated to healthcare and life sciences, which aim to support early-stage companies in these industries. With a commitment to fostering entrepreneurship, F Prime leverages its extensive insights, domain expertise, and relationships to assist entrepreneurs in building impactful companies, all while avoiding the pressures of external fundraising.

Flagship Pioneering, established in 2000 and based in Cambridge, is a venture capital firm that focuses on creating and developing innovative companies in healthcare, technology, renewable energy, and agriculture. The firm is dedicated to conceiving and nurturing first-in-category ventures aimed at transforming human health and sustainability. By leveraging science and entrepreneurial expertise, Flagship Pioneering explores unconventional ideas and guides them toward impactful outcomes through an evolutionary approach. The firm emphasizes the integration of innovative thinking, entrepreneurial leadership, and effective capital management to systematically generate groundbreaking companies. Additionally, Flagship Pioneering is committed to attracting and cultivating top talent in the scientific, entrepreneurial, and managerial fields, ensuring a robust foundation for its ventures.

Invus Financial Advisors, LLC is an employee-owned hedge fund sponsor based in New York, specializing in investments across various stages including special situations, venture capital, and growth equity. Founded in 2006, the firm manages over $4 billion in an evergreen fund and operates additional offices in London, Paris, and Hong Kong. Invus focuses on making minority investments and often acts as a lead investor or part of a consortium, emphasizing a flexible approach tailored to the unique needs of each company. The firm has a long-standing commitment to empowering owner-managers, aligning its incentives with those of its partners, and recognizing that meaningful business transformation requires time and resilience. With a history of reinvesting capital from European families since its inception, Invus demonstrates a dedication to fostering long-term relationships and navigating challenges in pursuit of extraordinary performance.

The Massachusetts Life Sciences Center (MLSC) is a quasi-public agency established to implement the Massachusetts Life Sciences Act, a $1 billion initiative aimed at fostering growth in the life sciences sector. Located in Waltham, Massachusetts, MLSC is dedicated to creating jobs and enhancing scientific research to improve health outcomes. The Center focuses on financial investments in both public and private institutions that advance research, development, and commercialization in various fields, including biopharmaceuticals, medical devices, diagnostics, and digital health. By promoting innovation and facilitating collaboration within the Massachusetts life sciences community, MLSC plays a crucial role in supporting early-stage companies and driving advancements in therapeutics and infrastructure.

Enhanced Capital Partners, founded in 1999 and headquartered in New York, is a national investment firm that specializes in equity and debt investments in small and mid-sized companies across the United States. With over $400 million under management, the firm employs a flexible investment strategy aimed at promoting the growth and expansion of businesses. Enhanced Capital focuses on various sectors, including healthcare technology and technology, media, and telecommunications. As a subsidiary of P10 Holdings, it seeks to maximize the growth potential of companies poised for rapid development through its practical investment approach.

Perceptive Advisors LLC is an investment management firm founded in 1999 and headquartered in New York City, with an additional office in Boston. The firm specializes in the healthcare sector, focusing on biotechnology, pharmaceuticals, life sciences, diagnostics, digital health, medical devices, and healthcare services. It engages in venture capital and incubation, investing at various stages of a company's life cycle, including seed and Series A funding, as well as late-stage venture and public market investments. Perceptive Advisors employs a long/short equity strategy and utilizes hedging techniques, including equity options and index options, while conducting in-house research to inform investment decisions. The firm also manages separate client-focused equity portfolios and provides customized debt financing solutions through its Perceptive Credit Opportunities Fund. Its clientele includes institutional investors, financial institutions, investment funds, and high-net-worth individuals.

New Enterprise Associates, Inc. is a private equity and venture capital firm established in 1977 and headquartered in Menlo Park, California, with additional offices in India and China. The firm specializes in investments across various stages of company development, including seed, start-up, early stage, and later stage, with a focus on sectors such as information technology, healthcare, and energy technology. NEA's investment strategy encompasses a wide range of industries, including consumer internet, software, biotechnology, medical devices, and alternative energy. With over $19 billion in cumulative committed capital, the firm has a notable track record, having participated in more than 210 portfolio company IPOs and over 360 acquisitions. NEA aims to invest between $0.05 million and $20 million, targeting both domestic and international markets, particularly in Asia and the Americas.

The Engine is a venture firm established in 2016 by the Massachusetts Institute of Technology (MIT) that focuses on early-stage investments in technology-driven companies addressing significant global challenges. It aims to accelerate the transition from innovative ideas to impactful solutions by providing a supportive ecosystem that includes access to funding, infrastructure, and specialized resources. Located in Cambridge, Massachusetts, The Engine offers physical space for entrepreneurs and simplifies the legal processes necessary for bringing products to market. It fosters a collaboration between startups and investors who are committed to long-term growth and innovation, allowing startups to retain more control over their ventures. With the capacity to support up to 60 startups simultaneously, The Engine provides essential business planning, legal, and administrative support, enabling companies to validate their concepts and achieve market readiness.

5Y Capital is a private equity and venture capital firm based in Shanghai, China, specializing in seed, startup, early venture, and growth capital investments. Established in 1992, the firm focuses on a diverse range of sectors, including healthcare, technology, fintech, internet services, consumer services, media, and life sciences, among others. It aims to support entrepreneurs in building innovative companies, particularly in China and other emerging markets in Asia/Pacific. Managing approximately USD 5 billion in dual-currency funds, 5Y Capital attracts investments from global sources, including sovereign wealth funds and family offices. The firm typically makes initial investments exceeding USD 500,000 per portfolio company. 5Y Capital operates under the Morningside Group, which is committed to socially responsible investing, particularly in educational opportunities and scientific research.

Accomplice Management LLC is a venture capital firm that focuses on seed and early-stage investments in technology companies. It specializes in sectors such as cybersecurity, eSports, data analytics, software for small and medium-sized businesses, emerging hardware platforms, and marketplaces. Headquartered in Boston with an additional office in San Francisco, Accomplice is known for its community-driven investment approach, leveraging platforms like AngelList and Boston Syndicates to support and empower founders. The firm has established a strong presence in Boston while also extending its investments across the United States, Canada, and Europe. Accomplice was formerly known as Atlas Venture before splitting its technology and life sciences divisions in 2014, with the technology group adopting the Accomplice name. It is recognized as one of the most active early-stage venture capital firms in New England.

Alexandria Venture Investments, LLC is a venture capital firm established in 1996 and headquartered in Pasadena, California. As the strategic investment arm of Alexandria Real Estate Equities, it focuses on providing capital to seed, early-stage, and growth-stage companies within the healthcare sector. The firm emphasizes investments in biopharma, diagnostics, life sciences, research tools, agrifoodtech, and agtech. Alexandria Venture Investments aims to support innovative entities developing breakthrough technologies and therapies, leveraging its extensive industry knowledge and relationships with leading investors. Its approach is characterized by a commitment to fostering innovation and entrepreneurship in the life sciences and technology sectors.

Flybridge is a private equity firm based in Boston, Massachusetts, founded in 2002. The firm specializes in seed and early-stage investments, primarily focusing on the technology sector, including areas such as computer hardware, software, SaaS, and big data. Flybridge collaborates with entrepreneurs to harness the power of community in their ventures. Additionally, the company is involved in providing internet media and marketing services, as well as consulting, software development, and web design. Through its multifaceted approach, Flybridge aims to support and nurture innovative startups in the technology landscape.

Pillar is a venture capital firm based in Boston, established in 2016, that focuses on early-stage investments in technology-driven companies. The firm partners with founders from the inception of their ideas, providing initial capital and supporting their growth through connections, coaching, and community engagement. Pillar is particularly interested in high-potential ventures across various sectors, including machine intelligence, artificial intelligence, hardware, enterprise software, blockchain, digital health, and synthetic biology. The firm aims to back both first-time and experienced entrepreneurs, fostering the development of the next generation of impactful companies in the region.

ARCH Venture Partners, L.P. is a private equity and venture capital firm founded in 1986 and based in Chicago, Illinois, with additional offices across North America and South America. The firm specializes in early-stage and growth capital investments, primarily focusing on life sciences and biotechnology, but also covering a wide array of technology sectors such as advanced materials, communications technologies, and information technology. ARCH is recognized for its role in commercializing innovations developed at academic research institutions and national laboratories. It has raised over $3 billion through ten venture funds and has invested in more than 150 companies, often co-founding them with leading scientists and entrepreneurs. The firm typically invests between $50,000 and $150 million per company, aiming to enter at seed rounds to minimize risk, and seeks a seat on the Board of Directors for its portfolio companies. While primarily investing in the United States, ARCH also targets opportunities in Canada, Europe, and select countries in Asia, focusing on underserved geographic markets rich in scientific research and technological talent.

.406 Ventures, LLC is a Boston-based venture capital firm founded in 2005 that specializes in early-stage investments, particularly in the information technology sector. The firm focuses on innovative companies in areas such as IT security and infrastructure, digital health, cloud technology, financial technology, and next-generation software. .406 Ventures typically invests between $2 million and $5 million initially, with total investments ranging from $6 million to $10 million per company. The firm seeks to be the lead institutional investor and often acquires significant stakes, ranging from 20 percent to 80 percent. It aims to provide board representation and actively supports its portfolio companies with its extensive industry experience and networks. Additionally, .406 Ventures allocates capital for opportunistic investments in more mature companies where technological shifts present growth opportunities. The firm primarily targets companies located in the Northeast and Southeast regions of the United States.

Fidelity Investments is a privately owned investment manager based in Boston, Massachusetts, founded in 1946. The firm offers a wide range of financial services, including individual retirement accounts, 401(k) rollovers, annuities, discount brokerage, and wealth management. It serves a diverse clientele, including individual investors, businesses, financial advisors, and institutions. Fidelity manages equity, fixed income, and balanced mutual funds, investing in public equity and fixed income markets worldwide. The firm conducts in-house research to guide its investment decisions and supports over 32 million clients in achieving their financial goals. Additionally, Fidelity assists more than 22,000 businesses with employee benefit programs and collaborates with over 13,000 financial institutions to provide innovative investment and technology solutions.

SOSV is a global venture capital firm founded in 1995 and headquartered in Princeton, New Jersey. Specializing in seed-to-growth stage investments, SOSV operates multiple accelerator programs worldwide, including HAX for hardware, IndieBio and RebelBio for life sciences, Chinaccelerator and MOX for cross-border internet ventures, Food-X for innovative food solutions, and dlab for blockchain technology. The firm focuses on investments in revolutionary deep technologies aimed at improving human and planetary health, as well as cross-border markets, particularly in Asia. SOSV invests in approximately 150 startups annually, providing support through its resources to accelerate product development and scaling. Over its two-decade history, SOSV has established a strong reputation, consistently ranking among the top venture capital firms globally.

Bessemer Venture Partners is a $4 billion venture capital firm founded in 1911 and based in California, specializing in investments across consumer, enterprise, and healthcare sectors globally, from seed stage to growth. The firm supports founders by providing guidance and resources, starting with seed and Series A investments and maintaining involvement throughout the development of their companies. Bessemer has a diverse portfolio, having funded early-stage companies such as Pinterest, Blue Apron, Skype, and Twitch, and has played a role in the successful initial public offerings of 117 companies, including Twilio, Yelp, and LinkedIn. The firm also operates several specialized funds targeting various sectors, including information technology, software, and digital health, with a presence in key markets such as India and Israel.

Insight Partners is a global private equity and venture capital firm established in 1995, specializing in growth-stage investments in the software, internet, and data services sectors. Headquartered in New York City, with additional offices in London, Tel Aviv, and Palo Alto, the firm manages over $75 billion in assets and has invested in more than 750 companies worldwide. Insight Partners focuses on partnering with high-growth technology and software companies that are driving significant change in their industries. The firm aims to support visionary executives by providing practical, hands-on expertise throughout their growth journey, from initial investment to public offering. With a strong commitment to fostering a culture of growth and opportunity, Insight Partners has seen over 55 portfolio companies achieve IPO status.

Matrix Partners is a venture capital firm established in 1977, with offices in San Francisco, Cambridge, Shanghai, Beijing, Mumbai, and Bangalore. The firm focuses on seed, early-stage, late-stage, and growth capital investments across various sectors, including software, communications, artificial intelligence, fintech, digital health, and clean technology. With a commitment to building long-term relationships with entrepreneurs, Matrix Partners aims to support visionary founders in developing significant, industry-leading companies. The firm has a strong track record, having participated in hundreds of investments, with many of its portfolio companies achieving successful IPOs or profitable mergers and acquisitions. The team at Matrix Partners combines local insights with global expertise, comprising both former entrepreneurs and seasoned investors.

Bain Capital, founded in 1984 and headquartered in Boston, Massachusetts, is a prominent private equity firm that specializes in a diverse range of investment strategies, including private equity, venture capital, and credit products. The firm manages over $95 billion in assets and has a global presence with 19 offices across four continents. Bain Capital focuses on various sectors, such as healthcare, technology, manufacturing, and consumer services. It operates through several subsidiaries, including Bain Capital Double Impact, which emphasizes impact investing in areas like sustainability and social good, and Bain Capital Life Sciences, which targets investments in biopharmaceuticals and medical technologies. Additionally, Bain Capital Specialty Finance provides direct loans to middle-market companies. The firm aims to align its interests with those of its investors, striving for both competitive financial returns and positive societal impact.

Samsara BioCapital LLC is a private equity firm established in 2016 and located in Palo Alto, California. The firm specializes in investing in biotechnology companies across the United States, providing capital and strategic support to help advance innovations in the life sciences sector. Samsara BioCapital aims to identify and cultivate promising biotechnological advancements that can transform healthcare and improve patient outcomes.

Hyperplane Venture Capital is an early-stage investment firm based in Boston, Massachusetts, established in 2015. The firm specializes in investing in technology companies that are leveraging machine intelligence, artificial intelligence, sensor technology, and cloud computing to address complex global challenges. Hyperplane focuses on partnering with exceptional founders who are innovating at the intersection of perception, communication, intelligence, and insight. The firm's investment strategy encompasses a wide range of sectors, including distributed systems, automation, robotics, virtual reality, and augmented reality, aiming to support the development of groundbreaking solutions in these fields.

Khosla Ventures is a venture capital firm established in 2004 by Vinod Khosla, a co-founder of Sun Microsystems. Based in Menlo Park, California, the firm manages over $5 billion and primarily invests in early-stage technology companies throughout the United States. Khosla Ventures provides capital, strategic advice, and venture assistance to entrepreneurs focused on breakthrough innovations across various sectors, including consumer technology, enterprise solutions, health, education, agriculture, and sustainable energy. The firm has a particular interest in high-risk, high-reward opportunities, often acting as a sole investor in "science or innovation experiments." Investment sizes typically range from $100,000 to over $20 million, allowing Khosla Ventures to support both traditional ventures and unconventional projects.

Launchpad Venture Group is a Boston-based angel investment group that provides funding to early-stage companies. The company looks for innovative, technology-driven startup companies addressing a significant market opportunity where an investment can make a difference. Launchpad has over 60 active investors. Members come from a variety of backgrounds and professions, including the technology, financial, and service communities. It is well connected to potential customers, service providers, partners, and future sources of financing. In a typical situation, Launchpad will invest between $100,000 and $500,000 and work with the company to proceed to the next stage.The company can help businesses grow by helping to recruit new members of the management team, develop strategic partners, refine product strategy, and raise the next round of venture funding. Launchpad Venture Group was founded on 2000 and is headquartered in Newton, Massachusetts.

Osage Partners LLC is a private equity and venture capital firm established in 1990, based in Bala Cynwyd, Pennsylvania, with an additional office in Princeton, New Jersey. The firm specializes in early-stage, mid-venture, and late-stage investments, primarily focusing on technology and healthcare sectors. It seeks to invest in a wide range of areas including business-to-business software, life sciences, healthcare IT, medical devices, diagnostics, and advanced materials. Osage Partners typically invests between $1 million to $4 million in companies with annual revenues ranging from $500,000 to $3 million, with a preference for leading investment rounds. The firm emphasizes partnerships with research universities to support startups that commercialize university technologies, having collaborated with over 80 institutions, including many of the top research universities in the U.S. Osage Partners is committed to actively participating in the governance of its portfolio companies to foster growth and innovation.

Founded in 2009, Founder Collective is a private equity firm based in Cambridge, Massachusetts, with an additional office in New York. The firm specializes in seed-stage investments, primarily in technology-related companies across various sectors, including software and telecommunications. Founder Collective manages $50 million in capital and typically invests between $0.2 million and $2 million in early-stage ventures. The firm is comprised of a network of successful entrepreneurs who leverage their experience to identify promising startups. While the firm’s investment focus is geographically centered on the East Coast, it maintains a global investment outlook, targeting companies with a significant information technology component.

Janus Henderson Group plc is a global asset management firm based in London, with additional offices in Jersey and Sydney. Founded in 1934, the company provides a range of investment services to institutional, retail, and high net worth clients. It manages client-focused equity and fixed income portfolios, as well as equity, fixed income, and balanced mutual funds. The firm invests in public equity and fixed income markets, along with real estate and private equity opportunities. As of March 2018, Janus Henderson manages approximately £265.3 billion in assets and employs over 2,000 staff worldwide, dedicated to helping clients achieve their long-term financial objectives.

Casdin Capital, LLC is an investment firm specializing in the life sciences and healthcare sectors. Founded in 2012 by Eli Casdin, who serves as the Chief Investment Officer, the firm employs a fundamental research approach to manage a long-short equity fund. Casdin Capital invests across a spectrum of opportunities, ranging from early-stage to late-stage private investments. As of October 2020, the firm manages approximately $2.2 billion in assets.

The Bill & Melinda Gates Foundation is a prominent grant-making organization co-founded by Bill and Melinda Gates in 2000, headquartered in Seattle, Washington, with additional offices in Washington, D.C.; New Delhi, India; Beijing, China; and London, United Kingdom. The foundation focuses on improving global health, enhancing education, and providing support to at-risk families, particularly in the Pacific Northwest. It actively promotes strategies that assist low-income families and works towards greater equality in various sectors. The foundation is also involved in investment management, overseeing an endowment that includes a diverse portfolio primarily in public equity and fixed income markets, while excluding tobacco-related investments. Its trustees include Bill Gates, Melinda Gates, and Warren Buffett.

T. Rowe Price is a publicly owned investment management firm founded in 1937 and headquartered in Baltimore, Maryland. The company serves a diverse clientele that includes individuals, institutional investors, retirement plans, and financial intermediaries. T. Rowe Price offers a wide array of investment strategies encompassing equity, fixed income, and private equity, with a particular focus on funding technology startups. The firm employs a combination of fundamental and quantitative analysis to guide its investment decisions, utilizing both in-house and external research. Additionally, T. Rowe Price is committed to socially responsible investing, prioritizing environmental, social, and governance factors. With a global presence, the firm operates offices in numerous locations worldwide, enhancing its ability to navigate various markets and deliver reliable investment solutions.

Highland Europe is a venture capital firm established in 2012, with headquarters in London and an additional office in Geneva. The firm specializes in investing in growth-stage companies within the internet, mobile, and software sectors across Europe. It typically targets investments ranging from €5 million to €75 million in businesses that have achieved over €10 million in annual revenues. Highland Europe aims to support management teams in accelerating growth and building sustainable, valuable companies. The firm is known for fostering strong relationships with founders and leaders at the board level, ensuring a collaborative approach to driving success.

Northpond Ventures is a venture capital firm based in Bethesda, Maryland, with additional offices in San Francisco and Cambridge. Founded in 2018, the firm specializes in growth capital investments across various sectors, including life sciences, biotechnology, diagnostics, digital health, and emerging technologies. Northpond Ventures aims to support innovative companies that are poised to make significant advancements in healthcare and technology, with a focus on building a better future through its strategic investments. As a Registered Investment Adviser, the firm is committed to fostering developments in therapeutics, artificial intelligence, machine learning, and medical technology.

Schooner Capital LLC is a private equity firm based in Boston, Massachusetts, that focuses on growth equity and alternative assets, including private equity and venture capital funds. The firm invests in private companies across various stages and sectors, with a particular emphasis on alternative energy and clean technology. Schooner Capital operates without outside limited partners, allowing it to maintain a long-term investment perspective. In addition to its domestic investments, the firm also targets emerging and frontier markets through specialized strategies, reflecting its commitment to global opportunities. Founded in 1971, Schooner Capital continues to adapt to the evolving landscape of private investments.

E14 Fund is a venture capital firm affiliated with MIT, established in 2013 and located in Cambridge, Massachusetts. The firm focuses on transforming innovative ideas from MIT into scalable businesses, covering a wide range of sectors including biotechnology, smart cities, consumer electronics, and information technology. E14 Fund invests between $0.5 million and $1 million in early-stage companies, particularly those involved in applied artificial intelligence, enterprise software, fintech, and health, among others. The firm emphasizes the importance of diversity and inclusion in fostering innovation, with a significant portion of its portfolio comprising companies founded by women and international entrepreneurs. Through a robust network of advisors, including industry experts and investors, E14 Fund helps its portfolio companies transition from prototypes to market-ready products, facilitating further investment and growth.

LaunchCapital, founded in 2008, specializes in seed and early-stage investments, providing essential capital for entrepreneurs looking to develop their businesses. With a portfolio of over 200 companies, LaunchCapital typically invests between $50,000 and $150,000, utilizing two distinct investment vehicles. LaunchCapital Ventures employs a traditional venture capital approach, focusing on equity investments in high-growth potential opportunities. In contrast, LaunchCapital Small Business combines equity and debt financing to support businesses aimed at generating immediate revenue and exhibiting consistent growth, often with a local or regional focus. The firm primarily invests in technology, consumer, and medical sectors and operates offices in Boston, New Haven, New York City, and the San Francisco/Bay Area.

EcoR1 Capital, LLC is an employee owned hedge fund sponsor. The firm provides its services to pooled investment vehicles. The firm also manages separate client-focused equity and fixed income portfolios. The firm invests in the public equity markets of the United States. It employs long/short strategy to make its investments. The firm typically invests in companies in biotechnology sector. EcoR1 Capital, LLC was founded in 2012 and is based in San Francisco, California.